Novartis AG (NVS)
Novartis Market Cap: 273.16B for Jan. 13, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Roche Holding AG | 338.91B |
| Amgen, Inc. | 175.89B |
| AstraZeneca PLC | 292.13B |
| Regeneron Pharmaceuticals, Inc. | 80.24B |
| Avidity Biosciences, Inc. | 10.90B |
Market Cap Related Metrics
| PE Ratio | 19.41 |
| PS Ratio | 5.153 |
| Price to Book Value | 6.162 |
| Price to Free Cash Flow | 16.36 |
| Price | 142.36 |
| Earnings Yield | 5.15% |
| Operating PE Ratio | 16.23 |
| Normalized PE Ratio | 18.44 |